Bionor Pharma ASA Announces Exploratory Study of Its Lead Therapeutic HIV-Vaccine Candidate Vacc-4x in Combination With Leading Cancer Drug
25 août 2011 08h00 HE | BionorPharma
OSLO, NORWAY--(Marketwire - Aug 25, 2011) - Bionor Pharma ASA (OSLO: BIONOR) announces plans to conduct an exploratory clinical study using Bionor Pharma's therapeutic HIV-vaccine candidate,...
Immune Network Ltd Logo
Immune Network to Start Clinical Trial of Oral Mycobacterium Vaccae in Tuberculosis Patients
10 août 2011 05h00 HE | Immune Network Ltd
VANCOUVER, British Columbia, Aug. 10, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF), reports that its business partner Immunitor company has launched a Phase 2 clinical trial of a...
Stellar Biotechnologies Announces a Strategic Agreement for Marketing and Sales With SAFC(R)
03 août 2011 16h05 HE | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Aug 3, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce they have entered into an agreement for marketing and...
Hemispherx Biopharma Receives U.S. Patent Office Notification of New Patent Granted for the Use of Ampligen(R) as an Influenza Virus Vaccine Adjuvant for Protection Against Pandemic Avian Influenza
19 juil. 2011 08h00 HE | Hemispherx Biopharma, Inc.
PHILADELPHIA, July 19, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced the granting of a new United States Patent for the use of...
Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS' HIV Vaccine VRX1273
18 juil. 2011 08h00 HE | VIRxSYS Corporation
ROME and GAITHERSBURG, MD--(Marketwire - Jul 18, 2011) - Researchers from VIRxSYS Corporation, the Gaithersburg, Maryland-based biotechnology company, today presented data indicating that a simian...
Expert Roundtable Explores Recent Advances in Cancer Immunotherapy
30 juin 2011 08h00 HE | MD Becker Partners LLC
NEW YORK, June 30, 2011 (GLOBE NEWSWIRE) -- The Cancer Research Institute (CRI) and MD Becker Partners announced today the release of a joint report titled, "Cancer Immunotherapy: A Roundtable...
Researchers to Present Results From Two VIRxSYS HIV Studies at the 6th International AIDS Society Meeting
28 juin 2011 10h06 HE | VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Jun 28, 2011) - VIRxSYS Corporation today announced that data from two HIV studies will be presented at the 6th International AIDS Society Conference on HIV...
Stellar Biotechnologies Announces Pre-IDE Meeting With FDA
10 mai 2011 09h45 HE | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - May 10, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces the completion of a pre-Investigational Device Exemption (pre-IDE) meeting...
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
08 mars 2011 08h55 HE | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - March 8, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed Michael R. McClurg to VP, Business Development & Marketing. His...
Immune Network Ltd Logo
Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical Site
24 janv. 2011 04h43 HE | Immune Network Ltd
VANCOUVER, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF) a company in the business of development and commercialization of immune therapies, announced...